BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20093695)

  • 1. Vascular endothelial growth factor expression and microvascular density in soft tissue sarcomas in dogs.
    de Queiroz GF; Dagli ML; Fukumasu H; Zavala AA; Matera JM
    J Vet Diagn Invest; 2010 Jan; 22(1):105-8. PubMed ID: 20093695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum vascular endothelial growth factor in dogs with soft tissue sarcomas.
    de Queiroz GF; Dagli ML; Meira SA; Matera JM
    Vet Comp Oncol; 2013 Sep; 11(3):230-5. PubMed ID: 22372675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas.
    Luong RH; Baer KE; Craft DM; Ettinger SN; Scase TJ; Bergman PJ
    Vet Pathol; 2006 Sep; 43(5):622-31. PubMed ID: 16966439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas.
    Yudoh K; Kanamori M; Ohmori K; Yasuda T; Aoki M; Kimura T
    Br J Cancer; 2001 Jun; 84(12):1610-5. PubMed ID: 11401313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical study of the expression of the hypoxia markers Glut-1 and Ca-IX in canine sarcomas.
    Abbondati E; Del-Pozo J; Hoather TM; Constantino-Casas F; Dobson JM
    Vet Pathol; 2013 Nov; 50(6):1063-9. PubMed ID: 23628694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of fibroblast growth factor 23 by canine soft tissue sarcomas.
    Hardcastle MR; Dittmer KE
    Vet Comp Oncol; 2016 Sep; 14(3):306-17. PubMed ID: 24923416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.
    Al-Dissi AN; Haines DM; Singh B; Kidney BA
    Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors.
    Avallone G; Stefanello D; Boracchi P; Ferrari R; Gelain ME; Turin L; Tresoldi E; Roccabianca P
    Vet Pathol; 2015 Nov; 52(6):1034-40. PubMed ID: 25795373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
    Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
    Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor in canine mammary tumors.
    Restucci B; Papparella S; Maiolino P; De Vico G
    Vet Pathol; 2002 Jul; 39(4):488-93. PubMed ID: 12126152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic significance of vascular endothelial growth factor-A (VEGF-A) and its receptor in canine prostate cancer.
    Leis-Filho AF; Lainetti PD; Kobayashi PE; Palmieri C; Amorim RL; Fonseca-Alves CE
    Prostate; 2021 Oct; 81(14):1021-1031. PubMed ID: 34320239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome-DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma.
    Kamstock D; Guth A; Elmslie R; Kurzman I; Liggitt D; Coro L; Fairman J; Dow S
    Cancer Gene Ther; 2006 Mar; 13(3):306-17. PubMed ID: 16138118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unclassified sarcomas: a study to improve classification in a cohort of Golden Retriever dogs.
    Boerkamp KM; Hellmén E; Willén H; Grinwis GC; Teske E; Rutteman GR
    J Vet Diagn Invest; 2016 Nov; 28(6):623-631. PubMed ID: 27698172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and expression of vascular endothelial growth factor, tumour necrosis factor-α and hypoxia inducible factor-1α in canine renal cell carcinoma.
    Yhee JY; Yu CH; Kim JH; Im KS; Kim NH; Brodersen BW; Doster AR; Sur JH
    J Comp Pathol; 2012; 147(2-3):129-38. PubMed ID: 22300704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of selected growth factor expression in canine spirocercosis (Spirocerca lupi)-associated non-neoplastic nodules and sarcomas.
    Dvir E; Clift SJ
    Vet Parasitol; 2010 Dec; 174(3-4):257-66. PubMed ID: 20888695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
    Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M
    J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
    Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
    J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma.
    Kamstock D; Elmslie R; Thamm D; Dow S
    Cancer Immunol Immunother; 2007 Aug; 56(8):1299-309. PubMed ID: 17502972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor concentrations from platelets correlate with tumor angiogenesis and grading in a spontaneous canine non-Hodgkin lymphoma model.
    Zizzo N; Patruno R; Zito FA; Di Summa A; Tinelli A; Troilo S; Misino A; Ruggieri E; Goffredo V; Gadaleta CD; Ranieri G
    Leuk Lymphoma; 2010 Feb; 51(2):291-6. PubMed ID: 20001231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tumor vascularisation in benign and malignant cardiovascular neoplasms: a comparison of cardiac myxoma and sarcomas of the pulmonary artery.
    Gaumann A; Strubel G; Bode-Lesniewska B; Schmidtmann I; Kriegsmann J; Kirkpatrick CJ
    Oncol Rep; 2008 Aug; 20(2):309-18. PubMed ID: 18636191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.